Educational intervention strategy to address cardiovascular risk in patients with high blood pressure
DOI:
https://doi.org/10.70099/BJ/2024.01.01.23Keywords:
Arterial hypertension, Cardiovascular risk, Healthy lifestyles, Primary health careAbstract
Cardiovascular diseases (CVD) are the leading cause of preventable death worldwide and nationally. Faced with this problem, educational strategies are essential in preventing and managing CVD. Aim: This study aimed to develop an academic intervention strategy to address cardiovascular risk (CVR) in patients with high blood pressure (HTN). A quasi-experimental study was carried out in which CVR and lifestyle habits were determined through the Globorisk and FANTASTIC Scale, respectively, before the educational intervention and after it, in a population of 97 patients of 40 to 79 years of age with primary HTN in the period from March to August 2021. The intervention consisted of educational strategies to promote healthy lifestyle habits and the prescription of an individualized eating plan according to the needs of the participants. Results: After the intervention, blood pressure control was obtained in 28.86% of the study population, body mass index decreased by 3.1%, CVR decreased by 11.34%, and healthy lifestyles improved by 9.15% (p=0.000) in all variables. Conclusions: In patients with HTN, educational interventions to promote healthy lifestyles improve CVR factors.
References
1. Organización Mundial de la Salud. Las 10 principales causas de muerte. OMS. 2020. p. 1-14.
2. World Health Organization (WHO). WHO reveals leading causes of death and disability worldwide: 2000-2019. World Health Organization (WHO). 2020;(1):https://www.who.int/news/item/09-12-2020-who-revea.
3. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study. Journal of the American College of Cardiology. 2020;76(25):2982. Doi: 10.1016/j.jacc.2020.11.010
4. Zhou B, Bentham J, Di Cesare M, Bixby H, Danaei G, Cowan MJ, et al. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet (London, England). 2017;389(10064):37. Doi: 10.1016/S0140-6736(16)31919-5
5. Costa R, Gutiérrez A, Valdivieso D, Carpio L, Cuadrado F, Núñez J. Encuesta STEPS Ecuador 2018. 2018.
6. Instituto Nacional de Estadística y Censos. Ecuador - Estadísticas Hospitalarias Camas y Egresos 2018. 2018. 2018.
7. Freire WB, Ramírez-Luzuriaga MJ, Belmont P, Mendieta MJ, Silva-Jaramillo K, Romero N, et al. Encuesta Nacional de Salud y Nutrición 2012. Ensanut-Ecu 2012. Quito; 2014.
8. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e563-95. Doi: 10.1161/CIR.0000000000000677
9. Butler T, Kerley CP, Altieri N, Alvarez J, Green J, Hinchliffe J, et al. Optimum nutritional strategies for cardiovascular disease prevention and rehabilitation (BACPR). Heart. 2020;106(10):724-31. Doi: 10.1136/heartjnl-2019-315499
10. Delgado-Lista J, Alcala-Diaz JF, Torres-Peña JD, Quintana-Navarro GM, Fuentes F, Garcia-Rios A, et al. Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial. The Lancet. 2022;399(10338):1876-85. Doi: 10.1016/S0140-6736(22)00122-2
11. Barrea L, Verde L, Suárez R, Frias-Toral E, Vásquez CA, Colao A, et al. Sex-differences in Mediterranean diet: a key piece to explain sex-related cardiovascular risk in obesity? A cross-sectional study. J Transl Med. 2024;22(1):44. Doi: 10.1186/s12967-023-04814-z
12. Barrea L, Verde L, Simancas-Racines D, Zambrano AK, Frias-Toral E, Colao A, et al. Adherence to the Mediterranean diet as a possible additional tool to be used for screening the metabolically unhealthy obesity (MUO) phenotype. J Transl Med. 2023;21(1):675. Doi: 10.1186/s12967-023-04546-0
13. Muscogiuri G, Verde L, Sulu C, Katsiki N, Hassapidou M, Frias-Toral E, et al. Mediterranean Diet and Obesity-related Disorders: What is the Evidence? Curr Obes Rep. 2022;11(4):287-304. Doi: 10.1007/s13679-022-00481-1
14. Grillo A, Salvi L, Coruzzi P, Salvi P, Parati G. Sodium Intake and Hypertension. Nutrients. 2019;11(9):1970. Doi: 10.3390/nu11091970
15. Suárez R, Diaz P, Sarmiento-Andrade Y, Cadena M, Alvarez L, Frias-Toral E. Evaluación del estilo de vida con el riesgo de diabetes mellitus tipo 2 en trabajadores universitarios ecuatorianos. Revis Bionatura. 2023;8(2):6. Doi: 10.21931/RB/2023.08.02.6
16. Cicero AFG, Veronesi M, Fogacci F. Dietary Intervention to Improve Blood Pressure Control: Beyond Salt Restriction. High Blood Pressure & Cardiovascular Prevention. 2021;28(6):547. Doi: 10.1007/s40292-021-00474-6
17. Borgi L, Muraki I, Satija A, Willett WC, Rimm EB, Forman JP. Fruit and Vegetable Consumption and the Incidence of Hypertension in Three Prospective Cohort Studies. Hypertension (Dallas, Tex : 1979). 2016;67(2):288-93. Doi: 10.1161/HIPERTENSIONAHA.115.06497
18. Grosso G, Laudisio D, Frias-Toral E, Barrea L, Muscogiuri G, Savastano S, et al. Anti-Inflammatory Nutrients and Obesity-Associated Metabolic-Inflammation: State of the Art and Future Direction. Nutrients. 2022;14(6):1137. Doi: 10.3390/nu14061137
19. Jurik R, Stastny P. Role of nutrition and exercise programs in reducing blood pressure: A systematic review. Journal of Clinical Medicine. 2019;8(9):1393. Doi: 10.3390/jcm8091393
20. Sharman JE, La Gerche A, Coombes JS. Exercise and Cardiovascular Risk in Patients With Hypertension. American Journal of Hypertension. 2015;28(2):147-58. Doi: 10.1093/ajh/hpu191
21. Voglhuber J, Ljubojevic-Holzer S, Abdellatif M, Sedej S. Targeting Cardiovascular Risk Factors Through Dietary Adaptations and Caloric Restriction Mimetics. Frontiers in Nutrition. 2021;8:726. Doi: 10.3389/fnut.2021.758058
22. Cáceres-Vinueza S, Frias-Toral E, Suárez R, Daher-Nader J, Flor-Muñoz E, Márquez-Vinueza M, et al. Anthropometric indexes and cardiovascular risk in Ecuadorian university students: A comparison with international references. Revis Bionatura. 2023;8(3):89. Doi: 10.21931/RB/2023.08.03.89
23. Ramôa Castro A, Oliveira NL, Ribeiro F, Oliveira J. Impact of educational interventions on primary prevention of cardiovascular disease: A systematic review with a focus on physical activity. The European Journal of General Practice. 2017;23(1):59. Doi: 10.1080/13814788.2017.1284791
24. Wilson DMC, Nielsen E, Ciliska D. Lifestyle Assessment: Testing the FANTASTIC Instrument. Canadian Family Physician. 1984;30:1863-4, 1866.
25. Hajifathalian K, Ueda P, Lu Y, Woodward M, Ahmadvand A, Aguilar-Salinas CA, et al. A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys. The lancet Diabetes & endocrinology. 2015;3(5):339-55. Doi: 10.1016/S2213-8587(15)00081-9
26. Ministerio de Salud Pública. Hipertensión arterial: Guía de Práctica Clínica (GPC). Dirección Nacional de Normatización. 2019.
27. Goyer L, Dufour R, Janelle C, Blais C, L’Abbé C, Raymond É, et al. Randomized controlled trial on the long-term efficacy of a multifaceted, interdisciplinary lifestyle intervention in reducing cardiovascular risk and improving lifestyle in patients at risk of cardiovascular disease. Journal of behavioral medicine. 2013;36(2):212-24. Doi: 10.1007/s10865-012-9407-3
28. Martínez Morales HA. Comparación de la estimación del riesgo cardiovascular absoluto entre la escala Globorisk y la escala Framingham en pacientes de consulta externa de medicina interna del Hospital Central Dr. Ignacio Morones Prieto. 2020.
29. Lönnberg L, Ekblom-Bak E, Damberg M. Reduced 10-year risk of developing cardiovascular disease after participating in a lifestyle programme in primary care. En: Upsala Journal of Medical Sciences. Taylor and Francis Ltd; 2020. p. 250-6.
30. Brinks J, Fowler A, Franklin BA, Dulai J. Lifestyle modification in secondary prevention: Beyond pharmacotherapy. American Journal of Lifestyle Medicine. 2017;11(2):137-52. Doi: 10.1177/1559827616651402
31. Lidin M, Hellénius ML, Rydell-Karlsson M, Ekblom-Bak E. Long-term effects on cardiovascular risk of a structured multidisciplinary lifestyle program in clinical practice. BMC Cardiovascular Disorders. 2018;18(1):59. Doi: 10.1186/s12872-018-0792-6
32. Leiva AM, Petermann-Rocha F, Martínez-Sanguinetti MA, Troncoso-Pantoja C, Concha Y, Garrido-Méndez A, et al. Asociación de un índice de estilos de vida saludable con factores de riesgo cardiovascular en población chilena. Revista médica de Chile. 2018;146(12):1405-14. Doi: 10.4067/s0034-98872018001201405
Published
How to Cite
Issue
Section
Categories
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with BioNatura Journal agree to the following terms: Authors retain copyright and grant the BioNatura Institutional Publishing Consortium (BIPC) right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). This allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
